CVS Health Corp. (NYSE: CVS) stock surged in pre-market trading on Wednesday after the healthcare company reported Q3 results with revenues of $81.2 billion, a growth of 10% year-over-year and handsomely beating Street estimates by $4.4 billion. Adjusted earnings came in at $2.09 per share surpassing consensus estimates of $2. The company also raised its FY22 guidance and now expects adjusted EPS to range between $8.55 and $8.65 per share from its prior guidance in the range of $8.40 to $8.60 per share. CVS's acquisition of Signify Health worth $8 billion is on track to be completed in the first half of next year.
https://www.tipranks.com/news/cvs-health-surges-after-delivering-a-healthy-q3?utm_source=advfn.com&utm_medium=referral
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Dez 2022 até Jan 2023 Click aqui para mais gráficos CVS Health.
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Jan 2022 até Jan 2023 Click aqui para mais gráficos CVS Health.